Our Science
Pioneering 3D bioprinting technology for regenerative medicine and tissue engineering
3D Bioprinting Technology
Nanocellic is a company developing commercially viable tissue regeneration 3D bioprinters and bioink products based on 3D bioprinting systems for patient-customized complex tissue reconstruction.
Our advanced bioink formulations enable precise control over tissue properties, making it possible to recreate the complex functions and behaviors of native human organs with unprecedented accuracy.
Bioink Portfolio
Three specialized bioink formulations for different tissue types
Basic Bioink
Physical and chemical cross-linking hydrogel-based injectable bioink with technical differentiation
- •Injectable hydrogel-based bioink utilizing physical and chemical cross-linking reactions
- •Foundation for creating customized artificial scaffolds for tissue defects
Soft-Tissue Bioink
Injectable hydrogel-based bioink with immediate cross-linking for precise strength control
- •Injectable hydrogel-based bioink with immediate cross-linking for fine strength control
- •High biocompatibility and compatibility with FDM 3D bioprinter technology
- •Natural polymer-based soft tissue therapeutic bioink development
Hard-Tissue Bioink
Hydrogel-based bioink enabling bone regeneration with tunable strength properties
- •Hydrogel-based bioink with chemical cross-linking capable of loading bone regeneration materials (BMP, Hydroxyapatite, etc.)
- •Environment similar to human bone tissue with strength control through curing degree adjustment
- •Natural polymer-based hard tissue therapeutic bioink development
Key Advantages
Precision Engineering
Our bioinks enable precise control over tissue properties, allowing for customized scaffolds that match patient-specific needs.
Biocompatibility
Formulated with natural polymers and biocompatible materials that integrate seamlessly with living tissues.
Versatility
Three specialized formulations cover soft tissue, hard tissue, and basic applications across multiple therapeutic areas.
Clinical Translation
Designed for commercial viability and scalability, enabling rapid translation from research to clinical applications.
Continuous Innovation
Our research and development team is constantly advancing the field of regenerative medicine through rigorous scientific validation and clinical testing. We publish our findings in leading scientific journals and collaborate with leading institutions worldwide.
Ready to Transform Medicine?
Join us in revolutionizing regenerative medicine through advanced 3D bioprinting technology.